Alan B. Lancz & Associates, Inc. Medtronic PLC Transaction History
Alan B. Lancz & Associates, Inc.
- $108 Million
- Q3 2024
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 10,658 shares of MDT stock, worth $955,809. This represents 0.89% of its overall portfolio holdings.
Number of Shares
10,658
Previous 10,658
-0.0%
Holding current value
$955,809
Previous $838,000
14.44%
% of portfolio
0.89%
Previous 0.84%
Shares
8 transactions
Others Institutions Holding MDT
# of Institutions
2,243Shares Held
1.04BCall Options Held
7.1MPut Options Held
4.42M-
Vanguard Group Inc Valley Forge, PA127MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY112MShares$10 Billion0.2% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.4 Billion0.21% of portfolio
-
Capital Research Global Investors Los Angeles, CA31.7MShares$2.85 Billion0.56% of portfolio
-
Jpmorgan Chase & CO New York, NY28.6MShares$2.56 Billion0.2% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $119B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...